VR Adviser, LLC
- SEC CIK
- 0001615982
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 33
- 0 vs. Q1 2026
- Portfolio value
- $3.30B
- +$618.9M (+23.1%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| INMInMed Pharmaceuticals Inc. | Common Stock | 32,685 | $50.7K | <0.1% | +32,685 | New | History |
| RACCResearch Alliance Corp III | ORD SHS CL A | 300,000 | $3.21M | 0.1% | +300,000 | New | History |
| XFORX4 Pharmaceuticals, Inc | COM NEW | 1,934,253 | $9.03M | 0.3% | +1,603,728+485.2% | Added | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 500,000 | $13.2M | 0.4% | 00.0% | Unchanged | History |
| KRROKorro Bio, Inc. | COM | 1,009,500 | $13.3M | 0.4% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM NEW | 632,931 | $16.4M | 0.5% | 00.0% | Unchanged | History |
| PBLSParabilis Medicines, Inc. | Stock | 625,000 | $17.1M | 0.5% | +625,000 | New | History |
| ACHVAchieve Life Sciences, Inc. | COM | 2,751,032 | $18.0M | 0.5% | +2,751,032 | New | History |
| CTMXCytomX Therapeutics, Inc. | COM | 4,982,124 | $18.7M | 0.6% | −5,000,000−50.1% | Reduced | History |
| ARTVArtiva Biotherapeutics, Inc. | COM | 2,043,596 | $19.8M | 0.6% | +434,027+27.0% | Added | History |
| IPSCCentury Therapeutics, Inc. | COM | 8,695,652 | $21.3M | 0.6% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,379,965 | $25.1M | 0.8% | 00.0% | Unchanged | History |
| HELPCybin Inc. | COM NEW | 3,851,654 | $25.5M | 0.8% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 526,331 | $26.7M | 0.8% | −1,200,000−69.5% | Reduced | History |
| ANLAdlai Nortye Group Ltd. | ADS | 3,212,731 | $36.9M | 1.1% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 6,434,990 | $38.0M | 1.2% | 00.0% | Unchanged | History |
| CBIOCrescent Biopharma, Inc. | COM | 2,133,576 | $38.4M | 1.2% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 4,319,765 | $46.8M | 1.4% | 00.0% | Unchanged | History |
| RLMDRelmada Therapeutics, Inc. | COM | 6,844,305 | $47.4M | 1.4% | +2,000,925+41.3% | Added | History |
| MAZEMaze Therapeutics, Inc. | COM | 1,602,034 | $47.8M | 1.4% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 2,173,913 | $48.3M | 1.5% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM NEW | 3,041,719 | $56.0M | 1.7% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 3,257,917 | $59.8M | 1.8% | −624,792−16.1% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 1,642,166 | $63.6M | 1.9% | −357,834−17.9% | Reduced | History |
| JBIOJade Biosciences, Inc. | COM NEW | 3,220,364 | $71.6M | 2.2% | 00.0% | Unchanged | History |
| SVRASavara Inc | COM | 14,745,943 | $90.8M | 2.8% | +1,005,568+7.3% | Added | History |
| DMRADamora Therapeutics, Inc. | COM NEW | 3,603,595 | $93.7M | 2.8% | 00.0% | Unchanged | History |
| OCULOcular Therapeutix, Inc | COM | 10,346,926 | $101.6M | 3.1% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 1,180,000 | $115.0M | 3.5% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 2,985,448 | $265.0M | 8.0% | −700,000−19.0% | Reduced | History |
| ERASErasca, Inc. | COM | 17,891,812 | $327.8M | 9.9% | +1,509,000+9.2% | Added | History |
| ORKAOruka Therapeutics, Inc. | COM | 4,148,428 | $394.8M | 12.0% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 8,493,321 | $1.13B | 34.2% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (4)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| KALVKalVista Pharmaceuticals, Inc. | COM | 6,474,485 | $130.3M | 4.9% | History |
| ENGNenGene Therapeutics Inc. | COM | 4,771,414 | $32.5M | 1.2% | History |
| TENXTenax Therapeutics, Inc. | COM NEW | 1,675,262 | $26.8M | 1.0% | History |
| SEPNSepterna, Inc. | COM | 506,056 | $12.2M | 0.5% | History |